Use of a phospholipase D mutant of Corynebacterium pseudotubercu

Details Use of a phospholipase D mutant of Corynebacterium pseudotubercu Use of a phospholipase D mutant of Corynebacterium pseudotubercu

1995-04-04

1997-06-10

Caputa, Anthony C.

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

424 932, 424 934, 4242001, 4242351, 4242821, 424823, 424824, A61K 3905

Patent

active

056373031

ABSTRACT:
The present invention relates to a vaccine vector comprising a virulent corynebacterium or related organism which is incapable of expressing an active virulent factor or a non-virulent corynebacterium or related organism which synthesises an immuno protection effective amount of an antigen of a pathogenic organism and its use to stimulate a protective immune response against virulent members of this group.

REFERENCES:
patent: 3853990 (1974-12-01), Madigan et al.
patent: 4925792 (1990-05-01), Rappuoli
patent: 5085862 (1992-02-01), Klein et al.
Lea Master et al. Am. J. Vet. Res. 48(5):869-72 (see abstract) 1987.
Cameron et al. Onderstepoort J. Vet. Res. 39(1):11-24 1972 (see abstract).
Feinberg et al., Analytical Biochemistry,132, 6-13, 1983.
Hodgson et al., Nucleic Acids Research,18, 7, 1891, 1990.
Hodgson et al., Journal of Bacteriology,172, 3, 1256-1261, 1990.

Affiliated with

Also associated with

Rating

Use of a phospholipase D mutant of Corynebacterium pseudotubercu does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a phospholipase D mutant of Corynebacterium pseudotubercu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a phospholipase D mutant of Corynebacterium pseudotubercu will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-762988